You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ferumoxytol MRI

Showing 1 - 25 of 8,607
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic

Recruiting
  • Central Nervous System Neoplasm
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 2, 2022

Osteomyelitis Trial in Albuquerque (Ferumoxides 11.2Mg Solution for Injection)

Completed
  • Osteomyelitis
  • Ferumoxides 11.2Mg Solution for Injection
  • Albuquerque, New Mexico
    University of New Mexico
Jul 17, 2023

Childhood Brain Tumor, Recurrent Childhood Brain Tumor Trial in Portland (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Completed
Has Results
  • Childhood Brain Neoplasm
  • Recurrent Childhood Brain Neoplasm
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 11, 2022

Ferumoxytol Enhanced Hyperfine Low Field Strength MRI

Completed
  • Anemia, Hemolytic
  • Hyperfine Portable MRI
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Dec 16, 2022

Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Portland (drug, other, procedure,

Terminated
Has Results
  • Lung Carcinoma Metastatic in the Brain
  • Stage IV Lung Non-Small Cell Cancer AJCC v7
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 14, 2022

IC - Interstitial Cystitis Trial in Pittsburgh (Ferumoxytol, Gadobutrol)

Recruiting
  • IC - Interstitial Cystitis
  • Pittsburgh, Pennsylvania
    UPMC Magee Women's Hospital
Apr 10, 2023

Glioblastoma Trial in Columbus, Portland (Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol,

Completed
  • Glioblastoma
  • Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Columbus, Ohio
  • +1 more
Mar 11, 2022

Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland

Recruiting
  • Hereditary Pancreatic Carcinoma
  • +2 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Ferumoxytol
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 16, 2022

Pediatric Congenital Heart Disease Trial in Los Angeles (ferumoxytol, gadofosveset)

Completed
Has Results
  • Pediatric Congenital Heart Disease
  • Los Angeles, California
    UCLA Medical Center
Nov 22, 2022

Brain Tumor Trial (Ferumoxytol, Magnetic Resonance Imaging)

Withdrawn
  • Brain Neoplasm
  • (no location specified)
Nov 3, 2021

Stage IIB Esophageal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7 Trial

Withdrawn
  • Stage IIB Esophageal Cancer AJCC v7
  • +4 more
  • (no location specified)
Sep 8, 2021

Osteonecrosis Trial in Stanford (Ferumoxytol-enhanced magnetic resonance imaging, Magentic Resonance Imaging)

Enrolling by invitation
  • Osteonecrosis
  • Ferumoxytol-enhanced magnetic resonance imaging
  • Magentic Resonance Imaging
  • Stanford, California
    Lucile Packard Children's Hospital
Aug 19, 2021

Metastatic Malignant Tumor in the Brain, Primary Brain Tumor Trial in Portland (3 Tesla Magnetic Resonance Imaging, Dynamic

Terminated
  • Metastatic Malignant Neoplasm in the Brain
  • Primary Brain Neoplasm
  • 3 Tesla Magnetic Resonance Imaging
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 3, 2021

Migraine Headache, Migraine Without Aura Trial in Glostrup (Feraheme, Cilostazol, USPIO-MRI)

Completed
  • Migraine Headache
  • Migraine Without Aura
  • Glostrup, Denmark
    Rigshospitalet Glostrup
Jul 26, 2022

Intracranial Atherosclerosis Trial in Chicago (Feraheme)

Recruiting
  • Intracranial Atherosclerosis
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7 Trial in Portland

Terminated
  • Locally Advanced Rectal Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 2, 2021

Head Neck Cancer Trial in Houston (Magnetic Resonance Imaging (MRI), Ferumoxytol)

Terminated
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 15, 2021

Stroke, Intracranial Aneurysm, Intracranial Atherosclerosis Trial in New Haven (Ferumoxytol Injectable Product)

Enrolling by invitation
  • Stroke
  • +2 more
  • Ferumoxytol Injectable Product
  • New Haven, Connecticut
    Yale University
Feb 7, 2022

Fetal Growth Retardation Trial in Madison (Ferumoxytol infusion, MRI scan)

Completed
  • Fetal Growth Retardation
  • Ferumoxytol infusion
  • MRI scan
  • Madison, Wisconsin
    University of Wisconsin-Madison
Oct 27, 2021

Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • +2 more
  • Ferumoxytol infusion
  • +2 more
  • Salt Lake City, Utah
    University of Utah Health Imaging and Neurosciences Center
Jun 22, 2022

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

Completed
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 12, 2022

Urinary Bladder Tumors Trial in Pittsburgh (Magnetic Resonance Imaging, Gadobutrol intravesical administration (4mM),

Recruiting
  • Urinary Bladder Neoplasms
  • Magnetic Resonance Imaging
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 7, 2022

Soft Tissue Sarcoma Trial in Boston (Ferumoxytol)

Withdrawn
  • Soft Tissue Sarcoma
  • Boston, Massachusetts
  • +3 more
Oct 14, 2020

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)

Completed
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023